A Phase 1, Open-label, Randomized, 3-period Crossover Study Evaluating the Relative Bioavailability of SPD489 When the Contents Are Emptied Into a Soft Food and Orange Juice in Healthy Adult Subjects
Phase of Trial: Phase I
Latest Information Update: 11 Jan 2019
Price : $35 *
At a glance
- Drugs Lisdexamfetamine (Primary)
- Indications Attention-deficit hyperactivity disorder; Bipolar depression; Eating disorders; Major depressive disorder
- Focus Pharmacokinetics
- Sponsors Shire
- 31 Aug 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Aug 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 04 Jul 2013 New trial record